Leading Pharmaceutical Manufacturing Partner for Itraconazole 130 mg (B.P.) Special Orders

As a trusted and globally recognized pharmaceutical manufacturer, Taj Pharma Group of Companies is pleased to announce a special batch production program for ITRACONAZOLE 130 MG (B.P.). This initiative has been designed to support pharmaceutical distributors, importers, marketing companies, healthcare organizations, government procurement agencies, and private-label pharmaceutical brands seeking a reliable manufacturing partner for high-quality antifungal formulations.

With decades of expertise in pharmaceutical development, manufacturing, export, and regulatory compliance, we offer comprehensive third-party manufacturing services tailored to meet the evolving demands of international healthcare markets.

About Taj Pharma Group of Companies

Taj Pharma Group stands among India’s leading pharmaceutical manufacturers and exporters, delivering world-class pharmaceutical formulations to global markets. Our manufacturing operations are supported by state-of-the-art facilities and highly qualified professionals dedicated to maintaining the highest standards of pharmaceutical excellence.

The group comprises:

  • Taj Pharmaceuticals Ltd.
  • Taj Pharma India Ltd.
  • Taj Lifesciences Pvt. Ltd.

Our facilities are strategically located in:

  • Sarigam, Gujarat
  • Vapi, Gujarat
  • Kalgam, Gujarat

All facilities operate under stringent quality systems and are compliant with international pharmaceutical manufacturing requirements.

WHO-GMP Certified Manufacturing Excellence

Quality remains the foundation of our pharmaceutical manufacturing operations. Our manufacturing facilities are certified and operated in accordance with internationally recognized standards, including:

  • WHO-GMP Certification
  • ISO 9001:2018 Compliance
  • PIC/S-Oriented Manufacturing Systems
  • GLP-Compliant Operations
  • Stringent Quality Assurance Programs
  • Advanced Quality Control Laboratories

Every product manufactured by Taj Pharma undergoes extensive testing to ensure compliance with pharmacopeial standards and regulatory specifications.

Special Manufacturing Opportunity: Itraconazole 130 mg (B.P.) Capsules

What is Itraconazole 130 mg (B.P.)?

Itraconazole 130 mg (B.P.) is a broad-spectrum antifungal medication used for the treatment and management of various fungal infections. It belongs to the triazole class of antifungal agents and is widely prescribed by healthcare professionals worldwide.

The growing prevalence of fungal infections has significantly increased the demand for high-quality itraconazole formulations in both developed and emerging pharmaceutical markets.

Therapeutic Applications of Itraconazole

Itraconazole is commonly prescribed for:

  • Aspergillosis
  • Blastomycosis
  • Histoplasmosis
  • Onychomycosis
  • Dermatophytosis
  • Systemic fungal infections
  • Pulmonary fungal diseases
  • Chronic fungal skin infections
  • Opportunistic fungal infections

The increasing awareness of fungal disease management has created substantial market opportunities for pharmaceutical companies seeking reliable sources of quality itraconazole products.

Why Partner with Taj Pharma for Itraconazole Manufacturing?

Customized Manufacturing Solutions

We understand that every client has unique requirements. Our manufacturing model is designed to provide:

  • Flexible batch sizes
  • Private labeling services
  • Custom packaging options
  • Country-specific regulatory support
  • Market-specific artwork development
  • Contract manufacturing arrangements
  • Third-party manufacturing partnerships

Scalable Production Capacity

Our facilities are equipped to handle:

  • Pilot-scale batches
  • Commercial-scale manufacturing
  • Large-volume export requirements
  • Government tender supplies
  • Institutional procurement contracts

This scalability enables clients to expand their market presence without investing in expensive manufacturing infrastructure.

Comprehensive Documentation Support

We provide extensive documentation packages that may include:

  • Certificate of Pharmaceutical Product (COPP)
  • Certificate of Analysis (COA)
  • Manufacturing License
  • Product Specifications
  • Stability Data
  • Method of Analysis
  • Batch Manufacturing Records
  • Free Sale Certificate
  • GMP Certificates
  • Product Dossiers
  • Regulatory Submission Support

Extensive Pharmaceutical Product Portfolio

Beyond Itraconazole 130 mg (B.P.), Taj Pharma Group manufactures a diverse range of pharmaceutical formulations covering multiple therapeutic segments.

Tablets

Our tablet manufacturing division produces:

  • Antibiotics
  • Antifungals
  • Antivirals
  • Antimalarials
  • Cardiovascular products
  • Anti-diabetic medications
  • Pain management formulations
  • Gastrointestinal medicines
  • Respiratory medicines

Capsules

We manufacture:

  • Hard gelatin capsules
  • HPMC vegetarian capsules
  • Sustained-release capsules
  • Modified-release capsules
  • Nutraceutical capsules
  • Antifungal capsules
  • Oncology-supportive products

Dry Syrups

Our pediatric and specialty dry syrup portfolio includes:

  • Antibiotic dry syrups
  • Nutritional formulations
  • Pediatric supplements
  • Specialty therapeutic products

Liquid Orals

Manufacturing capabilities include:

  • Syrups
  • Suspensions
  • Solutions
  • Oral drops
  • Nutritional tonics

Nutraceuticals

We develop and manufacture:

  • Multivitamin formulations
  • Mineral supplements
  • Immunity boosters
  • Sports nutrition products
  • Wellness products

Injectables

Our injectable division supports:

  • Sterile injectables
  • Antibiotic injections
  • Specialty therapeutic injectables
  • Hospital products

Global Pharmaceutical Export Expertise

Taj Pharma Group has established a strong international footprint through strategic partnerships and successful product registrations across multiple countries.

Our products are present in numerous regulated and semi-regulated markets, including:

  • Sri Lanka
  • Afghanistan
  • Cambodia
  • Yemen
  • Iraq
  • Malawi
  • Kenya
  • Tanzania
  • Nigeria
  • Various African markets
  • Asian markets
  • Middle Eastern countries

With more than 40 registered pharmaceutical products globally, we continue to expand our international presence through quality-focused manufacturing and regulatory excellence.

Contract Manufacturing and Third-Party Manufacturing Services

Pharmaceutical companies worldwide choose Taj Pharma because we provide end-to-end manufacturing solutions.

Our services include:

Private Label Manufacturing

Launch your pharmaceutical brand with confidence through customized manufacturing and branding solutions.

Loan License Manufacturing

Utilize our advanced facilities to manufacture products under your licensing arrangements.

Export-Oriented Manufacturing

Develop products specifically designed to meet international market requirements and registration standards.

Regulatory Support Services

Our experienced regulatory team assists clients in navigating complex pharmaceutical registration requirements across multiple jurisdictions.

Advanced Research and Product Development

Innovation drives our manufacturing strategy. Our research and development teams focus on:

  • New product development
  • Formulation optimization
  • Stability enhancement
  • Cost-effective manufacturing solutions
  • Bioequivalent product development
  • Regulatory compliance enhancement

This commitment enables us to provide pharmaceutical solutions that meet evolving healthcare needs worldwide.

Quality Assurance at Every Stage

Our quality management system covers:

Raw Material Qualification

Every incoming raw material undergoes rigorous testing before release for production.

In-Process Quality Control

Continuous monitoring ensures consistency throughout the manufacturing cycle.

Finished Product Testing

Products are evaluated against predefined specifications before market release.

Stability Monitoring

Comprehensive stability studies ensure product integrity throughout shelf life.

Business Collaboration Opportunities

We invite pharmaceutical companies, importers, distributors, healthcare organizations, government agencies, and marketing firms to explore collaboration opportunities for:

  • Itraconazole 130 mg (B.P.) Special Batch Orders
  • Contract Manufacturing
  • Third-Party Manufacturing
  • Export Partnerships
  • Private Label Projects
  • Product Registration Programs
  • Long-Term Supply Agreements

Our dedicated business development team works closely with clients to identify solutions that support sustainable business growth and market expansion.

Why Global Partners Choose Taj Pharma Group

Key advantages include:

  • WHO-GMP Certified Facilities
  • International Manufacturing Standards
  • Competitive Pricing Structure
  • Flexible Production Volumes
  • Strong Export Experience
  • Comprehensive Documentation Support
  • Reliable Supply Chain Management
  • Regulatory Expertise
  • Customized Packaging Solutions
  • Dedicated Customer Support

The announcement of our special batch production for ITRACONAZOLE 130 MG (B.P.) represents a valuable opportunity for pharmaceutical businesses seeking a dependable manufacturing partner with proven expertise and global capabilities.

At Taj Pharma Group, we remain committed to delivering superior pharmaceutical products through advanced manufacturing technologies, stringent quality systems, and customer-focused service. Whether your requirement involves private-label manufacturing, third-party production, export supply, or regulatory support, our experienced team is prepared to deliver customized pharmaceutical solutions that meet international standards and market expectations.

Organizations interested in participating in this special manufacturing program are encouraged to submit their product requirements, documentation needs, and market specifications to initiate discussions regarding production planning, regulatory support, and commercial collaboration.

Taj Pharma Group is pleased to announce a special batch production of Itraconazole 130 mg (B.P.), offering pharmaceutical distributors, importers, marketing companies, healthcare organizations, and government procurement agencies an opportunity to collaborate with one of India’s leading pharmaceutical manufacturers.

As a trusted WHO-GMP certified pharmaceutical company, Taj Pharma Group specializes in third-party manufacturing, contract manufacturing, private labeling, and global pharmaceutical exports. The group operates through Taj Pharmaceuticals Ltd., Taj Pharma India Ltd., and Taj Lifesciences Pvt. Ltd., with advanced manufacturing facilities located in Sarigam, Vapi, and Kalgam, Gujarat, India.

Itraconazole 130 mg (B.P.) is a widely used antifungal medication prescribed for the treatment of various fungal infections, including aspergillosis, histoplasmosis, dermatophytosis, onychomycosis, and other systemic fungal diseases. With increasing global demand for effective antifungal therapies, this special production program provides an excellent opportunity for pharmaceutical companies seeking a reliable manufacturing partner.

Taj Pharma Group manufactures a comprehensive range of pharmaceutical products, including tablets, capsules, dry syrups, liquid orals, nutraceuticals, and injectables. The company offers flexible production volumes, customized packaging, private-label solutions, and complete regulatory documentation support, including COA, COPP, GMP certificates, product dossiers, and stability data.

The company has a strong international presence with product registrations and business partnerships across Sri Lanka, Afghanistan, Cambodia, Yemen, Iraq, Malawi, Kenya, Tanzania, Nigeria, and other global markets. With more than 40 registered pharmaceutical products worldwide, Taj Pharma continues to expand its global footprint through quality manufacturing and regulatory excellence.

Organizations interested in partnering with Taj Pharma for Itraconazole 130 mg (B.P.), third-party manufacturing, export supply, or private-label projects are invited to share their product requirements and documentation needs to explore long-term business collaboration opportunities and market expansion strategies.